Skip to main content
. 2018 Feb 1;28(1):47–54. doi: 10.1089/cap.2017.0047

FIG. 1.

FIG. 1.

Distribution of patients according to highest intensity of any PAERS symptom by visit (OC). Patients affected by ≥1 PAERS symptom: baseline, n = 38; week 2 (end of lead-in treatment period), n = 37; and week 26 (end of OLE treatment period), n = 15. PAERS, Pediatric Adverse Events Rating Scale; OC, observed cases; OLE, open-label extension.